Table 3.
First author | Subtyping method | Molecular subtypes | Clinical significance |
---|---|---|---|
Collisson EA | Transcriptional profiles | 3 subtypes: classical, quasi-mesenchymal, exocrine-like | Classical subtype - GATA6 - erlotinib; QM subtype - KRAS - gemcitabine |
Moffitt RA | Transcriptional profiles | 4 subtypes: classical and basal-like tumor subtypes and normal and activated stromal subtypes | / |
Waddell N | Structural variations | 4 subtypes: stable, locally rearranged, scattered, unstable | Unstable subtype - BRCA pathway - platinum-based therapy |
Bailey P | Transcriptional profiles | 4 subtypes: squamous, pancreatic progenitor, immunogenic, aberrantly differentiated endocrine exocrine | / |